EWGSOP2-defined sarcopenia

13 papers mention it1 finding

1 new paper in 30 daysSee all 13 papers on EWGSOP2-defined sarcopenia

“Cox models showed that, after adjustment for potential confounders, only EWGSOP2 definition predicted 3-year mortality (hazard ratio [HR] 1.84; 95% confidence interval [CI] 1.33-2.57).”

Comparing EWGSOP2 and FNIH Sarcopenia Definitions: Agreement and 3-Year Survival Prognostic Value in Older Hospitalized Adults: The GLISTEN StudyThe journals of gerontology. Series A, Biological sciences and medical sciences2019doi:10.1093/gerona/glz249

Associations

3-year mortality

upin humans1HR 1.84

1 study

EWGSOP2-defined sarcopenia is linked with a higher risk of 3-year mortality in humans after adjustment for potential confounders (HR 1.84, 95% CI 1.33–2.57).
“Cox models showed that, after adjustment for potential confounders, only EWGSOP2 definition predicted 3-year mortality (hazard ratio [HR] 1.84; 95% confidence interval [CI] 1.33-2.57).”
Humansafter adjustment for potential confounders3 yearsn = 610
Comparing EWGSOP2 and FNIH Sarcopenia Definitions: Agreement and 3-Year Survival Prognostic Value in Older Hospitalized Adults: The GLISTEN Study
The journals of gerontology. Series A, Biological sciences and medical sciencesOct 20, 2019

Latest

5 papers in 12 months

Clinical NutritionNov 12

Electrical body measure linked to death risk in older patients

Over 36 months, 46.1% of older hospital patients in the lowest phase-angle group died, compared with 25.1% in the highest group.Over 36 months, 46.1% of older hospital patients in the lowest phase-angle group died, compared with 25.1% in the highest group.

Cohort · 538 peopleBiomarkers